Divis Laboratories Ltd (DIVISLAB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532488 | NSE: DIVISLAB | Pharmaceuticals & Drugs | Large Cap

Divis Lab Share Price

6,433.05 -37.55 -0.58%
as on 05-Dec'25 12:24

Divis Laboratories Ltd (DIVISLAB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532488 | NSE: DIVISLAB | Pharmaceuticals & Drugs | Large Cap

DeciZen - make an informed investing decision on Divis Lab

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Divis Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
69.12
Market Cap:
1,71,774.1 Cr.
52-wk low:
4,941.7
52-wk high:
7,077.7

Is Divis Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Divis Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Divis Laboratories Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 35.6%28.8%21.7%28.5%25.4%32.1%35.1%19.4%16.5%20.5%-
Value Creation
Index
2.21.60.91.51.31.92.10.70.50.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3,7764,0643,8914,9465,3946,9698,9607,7677,8459,36010,029
Sales YoY Gr.-7.6%-4.3%27.1%9.1%29.2%28.6%-13.3%1%19.3%-
Adj EPS 41.54132.550.249.475110.565.359.681.493.6
YoY Gr.--1.4%-20.7%54.5%-1.5%51.8%47.4%-40.9%-8.8%36.6%-
BVPS (₹) 161.7201.8223.2262.1275.4350.2441.8481.8512.1564.9580.6
Adj Net
Profit
1,1021,0878621,3311,3111,9902,9331,7341,5822,1602,485
Cash Flow from Ops. 1,0381,1507769541,2161,9471,9122,4591,2611,653-
Debt/CF from Ops. 000.10.1000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.6%11.7%1.5%19.3%
Adj EPS 7.8%10.5%-9.7%36.6%
BVPS14.9%15.5%8.5%10.3%
Share Price 19% 11.6% 24.1% 5.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
28.322.515.320.718.42427.914.21215.116.3
Op. Profit
Mgn %
37.736.632.637.933.941.243.330.528.231.832.4
Net Profit
Mgn %
29.226.722.226.924.328.632.722.320.223.124.8
Debt to
Equity
00000000000
Working Cap
Days
245268371307294247239293277268169
Cash Conv.
Cycle
156144154142153126130182183170142

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Divis Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 94.7 93.6
TTM Sales (₹ Cr.) 9,850 10,029
BVPS (₹.) 578.3 580.6
Reserves (₹ Cr.) 15,298 15,360
P/BV 11.19 11.14
PE 68.33 69.12
From the Market
52 Week Low / High (₹) 4941.70 / 7077.70
All Time Low / High (₹) 7.70 / 7077.70
Market Cap (₹ Cr.) 1,71,774
Equity (₹ Cr.) 53.1
Face Value (₹) 2
Industry PE 40.7

Management X-Ray of Divis Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Divis Lab - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Divis Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3,7764,0643,8914,9465,3946,9698,9607,7677,8459,360
Operating Expenses 2,3582,6172,6293,0733,5714,1085,0795,3985,6396,391
Manufacturing Costs350368411462540617758897902881
Material Costs1,5051,5341,5341,8252,1092,3242,9673,0533,1293,725
Employee Cost 3615004565426218269469751,0941,243
Other Costs 142215227244302342407473514542
Operating Profit 1,4181,4471,2631,8731,8232,8613,8812,3692,2062,969
Operating Profit Margin (%) 37.6%35.6%32.4%37.9%33.8%41.1%43.3%30.5%28.1%31.7%
Other Income 977511315619063116345339352
Interest 5325722243
Depreciation 118123142169186256312343378402
Exceptional Items 0000000000
Profit Before Tax 1,3931,3951,2311,8551,8192,6663,6842,3692,1632,916
Tax 267335354502443682723545563725
Profit After Tax 1,1261,0608771,3531,3771,9842,9601,8241,6002,191
PAT Margin (%) 29.8%26.1%22.5%27.3%25.5%28.5%33.0%23.5%20.4%23.4%
Adjusted EPS (₹)42.440.033.051.051.974.8111.568.860.482.7
Dividend Payout Ratio (%)24%25%30%31%31%27%27%44%50%36%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 4,2935,3575,9256,9577,3109,29511,72812,76713,57114,969
Share Capital 53535353535353535353
Reserves 4,2405,3045,8726,9047,2579,24211,67512,71413,51814,916
Minority Interest0000000000
Debt4236631063400002
Long Term Debt0000000000
Short Term Debt4136631063400002
Trade Payables233446411492591763796762824910
Others Liabilities 3301,5901,9481,2401,4911,3292,0951,3341,5421,836
Total Liabilities 4,8987,4298,3478,7959,42511,38714,61914,86315,93717,717

Fixed Assets

Gross Block2,1961,7942,3732,6343,5144,6925,6246,3656,7607,868
Accumulated Depreciation7572353775467329881,2991,6432,0212,426
Net Fixed Assets 1,4391,5591,9962,0882,7823,7044,3254,7224,7395,442
CWIP 2644441204929207114702127781,022
Investments 8031,6311,8891,946971072778265
Inventories1,2081,3201,3511,7721,8642,1452,8293,0003,1843,236
Trade Receivables8819011,0141,1631,4131,6772,4241,7932,1562,731
Cash Equivalents 73791121151232,1562,8194,2143,9803,715
Others Assets 2301,4961,8641,2191,3529951,6818451,0181,506
Total Assets 4,8987,4298,3478,7959,42511,38714,61914,86315,93717,717

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 1,0381,1507769541,2161,9471,9122,4591,2611,653
PBT 1,3931,3951,2311,8551,8192,6663,6842,3692,1632,916
Adjustment 619432846018924014481115
Changes in Working Capital -155-37-219-500-218-264-1370419-607-554
Tax Paid -261-302-269-484-445-644-641-473-376-824
Cash Flow From Investing Activity -406-1,140-478-685-8375-2,195-2,707-269-804
Capex -396-377-274-733-1,183-910-713-473-1,003-1,438
Net Investments -67-831-285-431,056928-1,549-2,439434339
Others 56688191435767205300295
Cash Flow From Financing Activity -6312-314-246-1,091-35-532-797-799-799
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -2-2-1-4-6-1-00-2-2
Dividend Paid -5310-319-265-8500-531-796-796-796
Others -985623-236-34-1-1-1-1
Net Cash Flow 013-1723411,987-816-1,04519350

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)28.9121.9815.552119.323.928.1614.8912.1515.35
ROCE (%)35.5728.7521.6828.525.3632.0735.0619.3616.4620.45
Asset Turnover Ratio0.760.670.50.580.60.670.690.530.510.56
PAT to CFO Conversion(x)0.921.080.880.710.880.980.651.350.790.75
Working Capital Days
Receivable Days78798980868183989195
Inventory Days114112125114122105101136143125
Payable Days5681102909410696939385

Divis Laboratories Ltd Stock News

Divis Laboratories Ltd FAQs

The current trading price of Divis Lab on 05-Dec-2025 12:24 is ₹6,433.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Divis Lab stood at ₹1,71,774.1.
The latest P/E ratio of Divis Lab as of 04-Dec-2025 is 68.33.
The latest P/B ratio of Divis Lab as of 04-Dec-2025 is 11.19.
The 52-week high of Divis Lab is ₹7,077.7 and the 52-week low is ₹4,941.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Divis Lab is ₹9,850 ( Cr.) .

About Divis Laboratories Ltd

Divi’s Laboratories Limited is a Company limited by shares, incorporated and domiciled in India. The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. The Company is a public limited company and the Company’s equity shares are listed in BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) in India.

Business area of the company

The Company manufactures Generic APIs, Nutraceutical Ingredients and offers Custom Synthesis of APIs to Big Pharma providing a competitive advantage over the entire life cycle of the products.

Business Segments

  • Generic APIs
  • Custom Synthesis
  • Nutraceuticals

Products

  • Capecitabine 
  • Carbidopa
  • Diltiazem HCl 
  • Dextromethorphan Base 
  • Dextromethorphan HBr 
  • Fosphenytoin Sodium 
  • Gabapentin 
  • Iopamidol
  • Irbesartan 
  • Levetiracetam
  • Levodopa
  • Mesalamine 
  • Nabumetone 
  • Naproxen
  • Naproxen Sodium 
  • Niacin
  • Olmesartan Medoxomil 
  • Phenylephrine HCl 
  • Pregabalin
  • Proguanil HCl 
  • Quetiapine Fumarate 
  • Tamsulosin HCl 
  • Telmisartan 
  • Triprolidine HCl 
  • Valacyclovir HCl 
  • Valsartan 
  • Venlafaxine HCl 
  • Vigabatrin 

Awards

2001:

  • Occupational Health and Safety Management System (OHSAS-18001) 

2002:

  • May Day Award for Best Management 

2003:

  • Shreshtha Suraksha Puraskar 
  • Appreciation certificate for Meritorious performance in implementing the programmes of ‘Safe Guarding the Environment and Pollution Control’
  • Viswakarma Rashtriya Puraskar  

2004:

  • Good Practice in Cleaner Production and Pollution Control 

2005:

  • National Award for Excellence Water Management 2005 
  • Appreciation certificate for Meritorious performance in implementing the programmes of ‘Safe Guarding the Environment and Pollution Control & Plantation work’. 
  • May Day Award for Best Management 

2006:

  • National Award for Excellence Water Management and Certificate for Water efficient unit.
  • National Award for Excellence Water Management and Certificate for Water efficient unit - Beyond the fence. 
  • Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’. 

2007:

  • Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’. 

2008:

  • Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’ on the Occasion of the World Environment 
  • Finalist Certificate 

2009:

  • Certified and Awarded for ‘Best Green Belt Development’
  • Occupational Health and Safety Management System (OHSAS-18001:2007) 
  • ISO 14001: 2004 (Re-Certification) ‘Environment Management System’  

2011:

  • Best Green Belt Development. 

2012:

  • India Business Leader Award ‘First Generation Entrepreneur of the Year’
  • Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification)
  • ISO 14001: 2004 (Re-Certification) ‘Environment Management System’. 

2013:

  • ISO 14064 - 1: 2006 Green House Gas Accounting verification. 
  • May Day award for Best Management 

2014:

  • Winner of ‘Special Commendation’ for Golden Peacock Award for Corporate Social Responsibility 

2015:

  • Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification)
  • May Day award for Best Management 
  • ISO 14001: 2004 (Re-Certification) ‘Environment Management System’.  

2018:

  • Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification)
  • ISO 14001 : 2018 (Re- certification) ‘Environmental Management System’.
  • May Day award for Best Management 

Milestones

  • 1990: Inception of Divi’s as Divi’s Research Centre(DRC)
  • 1995: Setup First Manufacturing facility(Unit-1) near Hyderabad
  • 2000: First USFDA Inspection
  • 2002: Commenced New Manufacturing Facility (Unit 2) near Vishakhapatnam
  • 2003: Divi’s Labs listed on Indian Stock Exchange
  • 2007: Set up Nutraceuticals facility at Unit 2
  • 2008: First MFDS(Korea) inspection
  • 2010: Established  New Research Centre at Hyderabad
  • 2011: First EU GMP and Japan PMDA Inspection
  • 2012: First TGA Inspection
  • 2013: First Slovenian Medicines Agency inspection for Unit-II
  • 2014: Divi’s reaches a milestone of 8700 employees
  • 2014: First COFEPRIS inspection
  • 2015: New corporate office inaugurated at Hyderabad
  • 2015: New Pilot block with 160 Reactors and Kilo Lab
  • 2016: First Anvisa (Brazil) inspection
  • 2017: Divi’s reaches a milestone of 11,000 employees and becomes one of the largest employers in the combined state of Telangana/Andhra Pradesh
  • 2017: Reaches the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad
  • 2018: Market capital of $5B Reached
  • 2018: 10 new production blocks commissioned
  • 2018: Expanded the product portfolio to over 30 products
  • 2019: Setting up Manufacturing plant at Kakinada
  • 2019: Additional investment of $250M towards expansion of production blocks in Unit -I and Unit- II
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×